Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immune Recovery

Reconstitution of the CD45RO+ and CD20+ lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML

Abstract

Following bone marrow transplantation (BMT) investigations on the recovery of the B and T lymphocyte populations have focused on the peripheral blood and only marginally regard the bone marrow. An immunohistochemical and morphometric study was performed on 352 trephine biopsies derived from 123 patients with chronic myelogenous leukemia (CML) at standardized endpoints before and after allogeneic BMT and compared to a control group. The purpose of this investigation was to quantify the B-CD20+ and T-CD45RO+ lymphocyte subsets and to determine possible relationships with the occurrence of acute and chronic GVHD. Moreover, we studied the dynamics of lymphocyte repopulation in the post-transplant period, correlations with the total peripheral lymphocyte count and differences associated with sibling vs alternate HLA-compatible (unmanipulated) marrow grafts. Morphometric analysis revealed a very fast regeneration of CD45RO+ and CD20+ marrow lymphocytes in the first 2 weeks following BMT. In less than 2 months, in most patients, the post-transplant quantity of lymphocytes was comparable to that of the normal bone marrow. This finding was opposed to the profound depression of the absolute lymphocyte count in the peripheral blood. No relevant relationships could be calculated between engraftment status and the lymphocyte repopulation in the bone marrow. On the other hand, significant correlations were calculable between the development of (chronic and acute) GVHD including severity with the number of CD45RO+ lymphocytes. In non-related graft constellations a more frequent evolution of acute grade III + IV GVHD was detectable. This complication was accompanied by an increased quantity of CD45RO+ lymphocytes in the marrow. Bone Marrow Transplantation (2001) 27, 425–431.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Gratwohl A, Hermans J, Niederwieser D et al. Bone marrow transplantantion for chronic myeloid leukemia: long-term results Bone Marrow Transplant 1993 12: 509–516

    CAS  PubMed  Google Scholar 

  2. Appelbaum FR, Clift R, Radich J et al. Bone marrow transplantation for chronic myelogenous leukemia Semin Oncol 1995 22: 405–411

    CAS  PubMed  Google Scholar 

  3. Beelen DW, Graeven U, Elmaagacli AH et al. Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome Blood 1995 36: 2981–2990

    Google Scholar 

  4. Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse Br J Haematol 1997 99: 30–35

    Article  CAS  PubMed  Google Scholar 

  5. Lamparelli T, Van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience Bone Marrow Transplant 1997 20: 1057–1062

    Article  CAS  PubMed  Google Scholar 

  6. Van Rhee F, Szydlo RM, Hermans J et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogeneous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1997 20: 553–560

    Article  CAS  PubMed  Google Scholar 

  7. Clift RA, Anasetti C . Allografting for chronic myeloid leukaemia Baillière's Clin Haematol 1997 10: 319–336

    Article  CAS  Google Scholar 

  8. Dini G, Lamparelli T, Rondelli R et al. Unrelated donor marrow transplantation for chronic myelogenous leukaemia Br J Haematol 1998 102: 544–552

    Article  CAS  PubMed  Google Scholar 

  9. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962–968

    Article  CAS  PubMed  Google Scholar 

  10. Gale RP, Hehlmann R, Zhang MJ et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia Blood 1998 91: 1810–1819

    CAS  PubMed  Google Scholar 

  11. Giralt S, Szydlo R, Goldman JM et al. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry Blood 2000 95: 410–415

    CAS  PubMed  Google Scholar 

  12. Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation Bone Marrow Transplant 1990 5: 209–226

    CAS  PubMed  Google Scholar 

  13. Verma UN, Mazumder A . Immune reconstitution following bone marrow transplantation Cancer Immunol Immunother 1993 37: 351–360

    Article  CAS  PubMed  Google Scholar 

  14. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic marrow transplantation Bone Marrow Transplant 1993 12: 469–475

    CAS  PubMed  Google Scholar 

  15. Ottinger, HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 88: 2775–2779

    CAS  PubMed  Google Scholar 

  16. Storek J, Saxon A . Reconstitution of B-cell immunity following bone marrow transplantation Bone Marrow Transplant 1992 9: 395–408

    CAS  PubMed  Google Scholar 

  17. Ferrara JLM, Degg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667–674

    Article  CAS  PubMed  Google Scholar 

  18. Enright H, Davies SM, DeFor T et al. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host diseases are protective Blood 1996 88: 714–720

    CAS  PubMed  Google Scholar 

  19. Gallardo D, García-López J, Sureda A et al. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase Bone Marrow Tranplant 1997 20: 945–952

    Article  CAS  Google Scholar 

  20. Barrett AJ, van Rhee F . Graft-versus-leukaemia Baillière's Clin Haematol 1997 10: 337–355

    Article  CAS  Google Scholar 

  21. Atkinson K, Hansen JA, Storb R et al. T-cell subpopulation identified by monoclonal antibodies after human marrow transplantation Blood 1982 59: 1292–1298

    CAS  PubMed  Google Scholar 

  22. Linch DC, Knott LJ, Thomas PM et al. T-cell regeneration after allogeneic and autologous bone marrow transplantation Br J Haematol 1983 53: 441–458

    Article  Google Scholar 

  23. Storek J, Ferrara JL, Ku N et al. B cell reconstitution after bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993 12: 387–398

    CAS  PubMed  Google Scholar 

  24. Storek J, Witherspoon RP, Store R . T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life Bone Marrow Transplant 1995 16: 413–425

    CAS  PubMed  Google Scholar 

  25. Trenschel R, Bernier M, Delforge A et al. Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation Leuk Lymphoma 1998 30: 325–352

    Article  CAS  PubMed  Google Scholar 

  26. Storek J, Witherspoon RP, Webb D, Storb R . Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease Am J Hematol 1996 52: 82–89

    Article  CAS  PubMed  Google Scholar 

  27. Mason DY, Comans-Bitter M, Cordell JL et al. Antibody L26 recognizes an intercellular epitope on the B-cell-associated CD20 antigen Am J Pathol 1990 136: 1215–1222

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Norton AJ, Ramsay AD, Smith SH et al. Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues J Clin Pathol 1986 39: 399–405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Thaler J, Greil R Dietze O, Huber H . Immunohistology for quantification of normal bone marrow lymphocyte subsets Br J Haematol 1989 73: 576–577

    Article  CAS  PubMed  Google Scholar 

  30. Falini B, Martelli MF, Tarallo F et al. Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies Br J Haematol 1994 56: 365–386

    Article  Google Scholar 

  31. Knapp W, Rieber P, Dörken B et al. Towards a better definition of human leucocyte surface molecules Immunol Today 1998 10: 253–258

    Article  Google Scholar 

  32. Kaiserling E, Horny HP, Engst U, Walz R . Immunohistology for quantification of normal bone marrow lymphocyte subsets Br J Haematol 1989 72: 576–577

    Google Scholar 

  33. Horny HP, Wehrmann M, Griesser H et al. Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens Am J Clin Pathol 1993 99: 142–149

    Article  CAS  PubMed  Google Scholar 

  34. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes) J Histochem Cytochem 1984 32: 219–229

    Article  CAS  PubMed  Google Scholar 

  35. Koehne G, Zeller W, Stockschlaeder M, Zander AR . Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 149–156

    Article  CAS  PubMed  Google Scholar 

  36. Leitenberg D, Rappeport JM, Smith BR . B-cell precursor bone marrow reconstitution after bone marrow transplantation Am J Clin Pathol 1994 102: 231–236

    Article  CAS  PubMed  Google Scholar 

  37. Thiele J, Kvasnicka HM, Fischer R . Bone marrow histopathology in chronic myelogenous leukemia (CML) – evaluation of distinctive features with clinical impact Histol Histopathol 1999 14: 1241–1256

    CAS  PubMed  Google Scholar 

  38. Holan V, Kohno K, Minowada J . Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T-cells J Inter Res 1991 11: 319–325

    CAS  Google Scholar 

  39. Gibson FM, Malkovska V, Myint AA et al. Mechanism of suppression of normal hematopoietic activity by lymphokine-activated killer cells and their products Exp Hematol 1991 19: 659–663

    CAS  PubMed  Google Scholar 

  40. Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 1980–1987

    CAS  PubMed  Google Scholar 

  41. Svilang L, Pearson ADJ, Green MA et al. Immunopathology of early graft-versus-host disease – a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients Transplantation 1991 52: 1029–1036

    Article  Google Scholar 

  42. Sakamoto H, Michaelson J, Jones WK et al. Lymphocytes with a CD4+ CD8 CD3 phenotype are effectors of experimental cutaneous graft-versus-host disease Proc Natl Acad Sci USA 1991 88: 10890–10894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sale GE, Anderson P, Browne M, Myerson D . Evidence of cytotoxic T-cell destruction of epidermal cells in human graft-vs-host disease. Immunohistology with monoclonal antibody TIA-1 Arch Pathol Lab Med 1992 116: 622–625

    CAS  PubMed  Google Scholar 

  44. Diamond DJ, Chang KL, Jenkins KA, Forman SJ . Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation Transplantation 1995 59: 1436–1444

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are greatly indebted to Mrs B Rosenbach, Mrs M Wonschick and Mrs H Tilemann for their excellent technical assistance. This work was supported by a grant from the Dr M Scheel Foundation for Cancer Research (grant number: 70-2134-Th1).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Kvasnicka, H., Beelen, D. et al. Reconstitution of the CD45RO+ and CD20+ lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML. Bone Marrow Transplant 27, 425–431 (2001). https://doi.org/10.1038/sj.bmt.1702789

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702789

Keywords

Search

Quick links